- Home
- ALEC vs CSBR Comparison
ALEC vs CSBR Comparison
Compare ALEC & CSBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALEC
- CSBR
- Stock Information
- Founded
- ALEC 2013
- CSBR 1985
- Country
- ALEC United States
- CSBR United States
- Employees
- ALEC N/A
- CSBR N/A
- Industry
- ALEC Biotechnology: Biological Products (No Diagnostic Substances)
- CSBR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ALEC Health Care
- CSBR Health Care
- Exchange
- ALEC Nasdaq
- CSBR Nasdaq
- Market Cap
- ALEC 162.6M
- CSBR 135.5M
- IPO Year
- ALEC 2019
- CSBR 1986
- Fundamental
- Price
- ALEC $1.18
- CSBR $8.85
- Analyst Decision
- ALEC Buy
- CSBR Strong Buy
- Analyst Count
- ALEC 7
- CSBR 1
- Target Price
- ALEC $4.10
- CSBR $12.00
- AVG Volume (30 Days)
- ALEC 528.1K
- CSBR 44.5K
- Earning Date
- ALEC 05-07-2025
- CSBR 03-11-2025
- Dividend Yield
- ALEC N/A
- CSBR N/A
- EPS Growth
- ALEC N/A
- CSBR N/A
- EPS
- ALEC N/A
- CSBR 0.46
- Revenue
- ALEC $100,558,000.00
- CSBR $58,591,000.00
- Revenue This Year
- ALEC N/A
- CSBR $15.11
- Revenue Next Year
- ALEC $40.79
- CSBR $7.80
- P/E Ratio
- ALEC N/A
- CSBR $18.78
- Revenue Growth
- ALEC 3.60
- CSBR 19.03
- 52 Week Low
- ALEC $1.13
- CSBR $3.60
- 52 Week High
- ALEC $6.78
- CSBR $11.99
- Technical
- Relative Strength Index (RSI)
- ALEC 35.06
- CSBR 42.25
- Support Level
- ALEC $1.26
- CSBR $9.21
- Resistance Level
- ALEC $1.36
- CSBR $9.97
- Average True Range (ATR)
- ALEC 0.08
- CSBR 0.65
- MACD
- ALEC -0.00
- CSBR -0.10
- Stochastic Oscillator
- ALEC 18.92
- CSBR 31.45
About ALEC Alector Inc.
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.
About CSBR Champions Oncology Inc.
Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.